Today's Top Health News Story

No vote on healthcare bill this week in U.S. House

WASHINGTON (Reuters) - U.S. House leaders have decided against holding a vote on a reworked healthcare system overhaul this week after failing to find the necessary support, congressional aides said on Thursday. Learn More

 

More Top Health Stories

Home blood pressure monitors may not be accurate enough

(Reuters Health) – Even as doctors are increasingly relying on home blood pressure monitoring to manage patients with hypertension, many of the devices are too inaccurate to be useful, according to a small study. More »

 

Malaria, wiped out in U.S., still plagues American travelers

(Reuters Health) - U.S. public health officials declared victory over malaria in 1951, but the mosquito-borne disease continues to infect and kill American travelers, a new study shows. More »

 

FDA approves Novartis' leukemia treatment

(Reuters) - The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday. More »

 

Mystery deaths in Liberia linked to funeral: WHO

GENEVA (Reuters) - Eleven people have died and five are in hospital, Liberian officials said on Friday, after contracting a mystery illness the World Health Organisation (WHO) said was linked to attendance at the funeral of a religious leader. More »

 

Global med-tech firms, India locked in tussle after stent price sting

NEW DELHI/MUMBAI (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for stents - small wire-mesh structures used to treat blocked arteries - slashing prices that patients pay for some devices by about 75 percent. More »

 

FDA approves Bayer's Stivarga to treat most common liver cancer

(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Bayer AG's drug Stivarga to treat liver cancer, the first such approval in nearly a decade. More »

 

South Korea fines Novartis $49 million over kickbacks, suspends insurance payment

SEOUL (Reuters) - South Korea said on Thursday it has fined Swiss drugmaker Novartis 55.1 billion won ($48.80 million) for offering doctors kickbacks to recommend the company's drugs, and also suspended insurance coverage for some of its drugs. More »

 

Police-associated injury not on the rise in U.S.

(Reuters Health) - Despite increased attention to deaths and injuries resulting from clashes with police, U.S. emergency department visits for police-associated injuries have remained stable at about 51,000 a year since 2006, researchers say. More »

 

UK cancer fund was poor value and may have caused patient suffering

LONDON (Reuters) - A special U.K. Cancer Drugs Fund (CDF) set up in 2010 spent over 1.2 billion pounds ($1.55 bln) but failed to deliver value for patients or society and may have caused unnecessary suffering, an analysis has found. More »

 

News, Photo and Web Search